Hotline TAVI 2: outcomes with new and established devices
<p class="moderator speaker-name">Anchorperson: <span classs="personname">Stephan Baldus</span></p><p class="moderator speaker-name">Spokesperson: <span classs="personname">Tiffany Patterson</span></p><p class="moderator speaker-name">Discussants: <span classs="personname">Howard Herrmann, Harlan Krumholz, Thomas Pilgrim, Luca Testa</span></p>
<div class="intervention"><div class="interventionTitle">Pooled analysis of two randomised controlled trials comparing balloon-expandable TAVI valves</div><p class="speaker-intervention-name-img">Christian Juhl Terkelsen</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">TAVI with intra- vs. supra-annular self-expanding valves</div><p class="speaker-intervention-name-img">Pier Pasquale Leone</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Early ACURATE prime: multicenter study to evaluate safety and effectiveness</div><p class="speaker-intervention-name-img">Andreas Rück</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">ACURATE neo2 under-expansion in the ACURATE IDE study: a post-hoc analysis</div><p class="speaker-intervention-name-img">Raj Makkar</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div>